Plain-English translation of NCT07380906 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is collecting real-world information about genicular artery embolization (GAE), a minimally invasive procedure that blocks tiny blood vessels around the knee to reduce arthritis pain. Researchers want to understand whether this treatment leads to lasting pain relief and improved quality of life for people with knee arthritis that hasn't responded to other treatments like physical therapy or injections.
Many people with knee arthritis don't get enough relief from medications, injections, or physical therapy alone, and surgery isn't right for everyone. This study exists to learn whether this newer, less invasive procedure could be a good option for these patients and to figure out which patients are most likely to benefit.
You likely qualify if…
You likely don't qualify if…
You will receive the procedure as part of your regular medical care. After the procedure, you'll complete follow-up visits and fill out simple questionnaires about your pain and quality of life at 1, 3, 6, 12, 18, 24, and 36 months. Researchers will track both your improvement and any side effects using standard safety guidelines.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
United States
Enrollment target
~1,200 participants
Started
July 2025
Primary completion
April 2030
Age range
18 Years and older
Last updated on clinicaltrials.gov in June 2026.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.